Skip links
CONTACT US

Altimetrik Achieves SAFe® Gold Partner to Accelerate Digital Business for Enterprise Clients

Jump To Section

  • admin
  • 5 mins
Altimetrik Achieves SAFe® Gold Partner to Accelerate Digital Business for Enterprise Clients

Altimetrik Achieves SAFe® Gold Partner to Accelerate Digital Business for Enterprise Clients

DETROIT–(BUSINESS WIRE)–Altimetrik, a leading digital business enablement company, today announced that it is now a certified Scaled Agile Framework® (SAFe®) Gold Partner. As a Gold Partner of the Scaled Agile Partner Network, Altimetrik will leverage its expertise and resources to advise and support global clients to implement digital business initiatives through lean-agile transformations at scale. This achievement adds to Altimetrik’s pioneering approach to accelerating digital business and will facilitate its ability to engineer and deliver outcomes for clients of all sizes.

Altimetrik partners with clients across the globe to drive better digital business outcomes, which the company believes can be accelerated with a disciplined approach to adopting more agile ways of work. Agile Transformation At Scale, however, is not easy for large enterprises with complex organizational structures, long standing ways of work, and multi-faceted dependencies. This certification will enable Altimetrik to bring in Certified Scaled Agile practitioners (SPC) who can help clients strategize, plan, and deliver real and sustainable results through a Scaled Agile Transformation journey.

Altimetrik is now part of an expanding group of forward-looking Agilists within the SAFe community. Led by technology, innovation, and strategy, Altimetrik’s Agile practice has grown 10-fold over the last 18 months, which validates the market demand for these skills and experience. The company expects its SAFe Program Consultant (SPC) practitioner team to double in 2022 and will continuously develop new opportunities to grow quality revenue for its clients’. The company plans to continue developing its consulting services through regular hosting of public training classes and development of associated agile communities.

Visit to read more – www.businesswire.com

admin

admin

Latest Reads

Subscribe

Suggested Reading

Data Automation Is on the Rise

Data Automation Is on the Rise

Tech professionals return to IT companies

Tech professionals return to IT companies

‘Official yet?’: Has time come to end work-from-home?

‘Official yet?’: Has time come to end work-from-home?

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes